A detailed history of Nemes Rush Group LLC transactions in Viatris Inc stock. As of the latest transaction made, Nemes Rush Group LLC holds 739 shares of VTRS stock, worth $8,616. This represents 0.0% of its overall portfolio holdings.

Number of Shares
739
Previous 748 1.2%
Holding current value
$8,616
Previous $8.93 Million 12.05%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$10.05 - $12.02 $90 - $108
-9 Reduced 1.2%
739 $7.86 Million
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $2,918 - $3,504
-259 Reduced 25.72%
748 $8.93 Million
Q4 2023

Feb 09, 2024

SELL
$8.77 - $10.85 $254 - $314
-29 Reduced 2.8%
1,007 $10.9 Million
Q3 2023

Nov 09, 2023

SELL
$9.59 - $11.35 $2,800 - $3,314
-292 Reduced 21.99%
1,036 $10.2 Million
Q2 2023

Aug 02, 2023

BUY
$9.02 - $10.29 $11,978 - $13,665
1,328 New
1,328 $13.3 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.